Increased corticotropin-releasing hormone (CRH) and the associated glucocorticoid receptor resistance contribute to the upregulation of inflammatory cytokines and the maintenance of inflammation, whereas the activation of brain microglia by the same cytokines is a proposed mechanism underlying concomitant depression [70]. The gene discussed is NR3C1; the disease is depressive symptom measurement.